Heart Failure in Patients With Atrial Fibrillation Is Associated With a High Symptom and Hospitalization Burden: The RealiseAF Survey

Abstract BackgroundAtrial fibrillation (AF) and heart failure (HF) often coexist; the consequences of such coexistence are unclear. HypothesisHF in patients with AF is associated with poor outcomes. MethodsThis post hoc analysis of RealiseAF, a survey of AF patients, compared symptoms, hospitalizations, management, and AF control in patients with vs without HF. A total of 10,523 AF patients were analyzed according to presence/absence of HF. ResultsHistory of HF was present in 45.8%, and in more patients with permanent vs persistent, paroxysmal, or first‐episode AF (55.6%, 44.3%, 32.9%, and 29.8%, respectively; P 
Source: Clinical Cardiology - Category: Cardiology Authors: Tags: Clinical Investigations Source Type: research

Related Links:

CONCLUSIONS: Not all interventional procedures result in a mortality benefit. Medical therapy alone increases survival in many cardiac diseases. PMID: 32083425 [PubMed - as supplied by publisher]
Source: Minerva Cardioangiologica - Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
The health tracking market is booming. What with smart bracelets, smart beds and smart chest straps, the tracking industry has penetrated the lives of old and young from the time they wake up in the morning to the time they hit the bed at night (and beyond). It’s no wonder that user penetration is projected to reach 25% of the adult population by 2022 in the US alone and that these devices are being adopted by over 30% of individuals across all age groups. Naturally, I count among those adopters. I call myself a data geek, using the data accumulated from myriads of health trackers to help me make more informed hea...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Health Sensors & Trackers digital health digital technology health data digital health sensors Source Type: blogs
Authors: Grubb A, Mentz RJ Abstract Introduction: Both heart failure with reduced ejection fraction (HFrEF) and atrial fibrillation (AF) independently cause significant morbidity and mortality. Moreover, the two conditions commonly coexist and AF in the setting of HFrEF is associated with worse all-cause mortality, hospitalizations, and quality of life compared to HFrEF without AF. Despite the large burden of these conditions, there is no clear optimal clinical management strategy for when they occur together.Areas Covered: This review focuses on the pharmacological management of AF in HFrEF. Studies were identifie...
Source: Expert Review of Cardiovascular Therapy - Category: Cardiology Tags: Expert Rev Cardiovasc Ther Source Type: research
Atrial fibrillation (AF) is the most common arrhythmia and is associated with increased morbidity and mortality. Its prevalence is increasing with the aging of the population and there is a clear need for more reliable diagnosis and improved therapy. Current therapeutic approaches for AF have only moderate efficacy, substantial side effects and eminent limitations due to the complex treatment of concomitant thromboembolism, cardiac ischemia and heart failure [1,2]. Sex-related differences in the prevalence, presentation, associated co-morbidities and therapy outcomes further complicate the management of this important clinical condition [3].
Source: International Journal of Cardiology - Category: Cardiology Authors: Tags: Editorial Source Type: research
Type 2 diabetes (T2D) is a metabolic disorder of insulin resistance — a reduced sensitivity to the action of insulin — which leads to high blood sugar, or hyperglycemia. Approximately 12% of American adults have T2D, and more than one-third of Americans have prediabetes, a precursor to T2D. This is a major public health concern, as T2D dramatically increases risk for heart disease, including heart attacks, atrial fibrillation, and heart failure. The development and progression of T2D is affected by many factors. Some, such as a person’s race/ethnicity, age, and gender cannot be modified. Others, including...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Diabetes Exercise and Fitness Healthy Eating Heart Health Source Type: blogs
Publication date: Available online 14 February 2020Source: American Heart JournalAuthor(s): Bao-Oanh Nguyen, Michiel Rienstra, Anne H. Hobbelt, Jan G.P. Tijssen, Marcelle D. Smit, Robert G. Tieleman, Bastiaan Geelhoed, Dirk J. Van Veldhuisen, Harry J.G.M. Crijns, Isabelle C. Van Gelder, RACE 3 InvestigatorsAbstractAtrial fibrillation (AF) is a progressive disease, and maintenance of sinus rhythm is cumbersome. In this analysis of the Routine versus Aggressive risk factor driven upstream rhythm Control for prevention of Early atrial fibrillation in heart failure (RACE 3) trial we aimed to determine whether optimal treatment...
Source: American Heart Journal - Category: Cardiology Source Type: research
Peak left atrial longitudinal strain (PALS) can help identify left atrial appendage thrombus (LAAT) in patients with atrial fibrillation. Nevertheless, few studies have been performed in patients in sinus rhyt...
Source: Cardiovascular Ultrasound - Category: Radiology Authors: Tags: Research Source Type: research
PMID: 32062642 [PubMed - as supplied by publisher]
Source: Circulation Journal - Category: Cardiology Authors: Tags: Circ J Source Type: research
Although ∼20% of the elderly develop atrial fibrillation (AF), little is known about the mechanisms. Heart failure with preserved ejection fraction (HFpEF), which is associated with AF, is more common in aged females than in males
Source: Heart Rhythm - Category: Cardiology Authors: Source Type: research
Abstract BACKGROUND AND OBJECTIVES: The aim of this retrospective cohort study was to develop a new score (RA-CHADSV) (rheumatoid arthritis - congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke/transient ischemic attack/thromboembolism, and vascular disease), modified from the CHA2DS2-VASc score (congestive heart failure, hypertension, age ≥75 years (doubled), diabetes mellitus, stroke/transient ischemic attack (doubled), vascular disease, age 65-74 years, and female), in predicting the risk of ischemic stroke in rheumatoid arthritis (RA) patients without atrial fibrillation (AF)...
Source: Medicina (Kaunas) - Category: Universities & Medical Training Authors: Tags: Medicina (Kaunas) Source Type: research
More News: Atrial Fibrillation | Cardiology | Cardiovascular | Heart | Heart Failure | Hospital Management | Study